Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Eli Lilly & Co., the Fortune 500 pharma firm that makes weight-loss injection Zepbound (tirzepatide), has a comparable oral drug in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks spoke to Bloomberg TV on January 13, 2025.
Gam1983/Getty Images
